T. Rowe Price Investment Management, Inc.

Position in NVCR — NovoCure Ltd

CIK 1897612 BALTIMORE, MD

Position in NVCR

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$10,108,463

+$10,067,825 QoQ

Shares Held

927,382

+29406.3% QoQ

Ownership

0.801%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $1,106,407,711 across 15 Medical Devices names. NVCR ranks #10 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PODD	Insulet Corp	1,815,742	$381,015,301
2	ABT	Abbott Laboratories	2,764,429	$283,823,925
3	NEOG	Neogen Corp	10,162,715	$94,411,622
4	QDEL	QuidelOrtho Corp	5,629,965	$92,500,324
5	PRCT	PROCEPT BioRobotics Corp	3,273,794	$81,877,587
6	AVNS	Avanos Medical, Inc.	5,330,776	$74,684,171
7	HAE	Haemonetics Corp	597,155	$33,655,655
8	IRMD	Iradimed Corp	256,697	$24,709,653

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,108,463	927,382	+29406.3%	Shares	Sole	2026-05-15
2025-12-31	$40,638	3,143	-99.7%	Shares	Sole	2026-02-19
2025-09-30	$12,214,903	945,426	+31.7%	Shares	Sole	2025-11-14
2025-06-30	$12,781,379	718,055	-57.5%	Shares	Sole	2025-08-14
2024-12-31	$50,375,141	1,690,441	-39.8%	Shares	Sole	2025-02-14
2024-09-30	$43,859,858	2,806,133	+63.9%	Shares	Sole	2024-11-14
2024-06-30	$29,333,292	1,712,393	-9.4%	Shares	Sole	2024-08-14
2023-06-30	$78,469,694	1,890,836	+19.8%	Shares	Sole	2023-08-14
2023-03-31	$94,930,087	1,578,485	+3403.2%	Shares	Sole	2023-05-15
2022-12-31	$3,305,077	45,059	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.